HCS helps clients towards better-managed care, by providing state-of-the-art, end-to-end healthcare solutions in areas that include hospital management systems and decision support systems through its Healthcare Practice. HCS has considerable business and technology expertise, backed by specialists drawn from medical sciences, bio-medical engineering and information technology. We execute turnkey projects for hospitals and healthcare institutes in which we provide end-to-end solutions from hardware, software, networking, to fully integrated and scalable Internet solutions. Through our data warehousing and data mining expertise, we build decision support systems for clinical and critical pathways.
Management consultancy
Customer relationship management
Reengineering legacy systems
Customized application development and data warehousing
The Pharmaceuticals & Medical Products Practice:
Works with a diverse spectrum of organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals, medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We help clients address a full range of strategic, competitive, and operational issues. Our Pharmaceuticals & Medical Products Practice is mainly divided in the following areas.
Prescription Pharmaceuticals:
We advise clients on opportunities in licensing and alliances, portfolio management, and existing and emerging therapeutic areas and technologies. Because R&D pipelines and the search for the next blockbuster are essential to continued strong performance, we help clients develop sound R&D strategies.
OTC Medicines:
As more prescription drugs become available over the counter, we help clients assess their opportunities, explore partnerships with consumer product companies, understand the regulatory hurdles, and measure the impact on prescription sales.
Biotechnology:
The mapping of the human genome is leading the charge for new drugs and treatment regimens. We help pharmaceutical biotechnology companies identify promising technologies, new entities, and improved therapies based on genomics, informatics, proteomics, and other biotech advances. We also assist clients in developing partner, acquisition, and licensing strategies.
